Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

How clinicians can impede clinical trial recruitment

Don S. Dizon, MD
Conditions
August 17, 2018
Share
Tweet
Share

asco-logo In the second week of April, I headed to San Francisco where I took part in the SWOG Semi-Annual Meeting. To those who might be unfamiliar with us, SWOG is a member organization of the National Clinical Trials Network (NCTN) and is tasked in running clinical trials across disease sites and scenarios, from prevention to treatment to survivorship and palliative care. Those involved in SWOG come from across the country twice a year to meet, learn, teach, and plan — all of this in the most interactive and inclusive way possible. Thanks to the leadership in our patient advocacy group (shout out to Wendy Lawton and Rick Bangs!), patient advocates, who are embedded more and more into aspects of trial design at its earliest point, are important contributors to this meeting.

The goal is to launch clinical trials across the country, and once that happens, to ensure they successfully accrue. We spend a lot of time trying to improve accrual — making sure our investigators open as many trials as possible, supporting them once that happens, and then raising awareness among our patients, communicating in a way that is straightforward and clear, without overly relying on scientific and technical lingo. As I prepared for the SWOG meeting, I was reminded of one thing: that we as clinicians can sometimes be our own barrier to trial accrual.

I recall one instance when I was in a tumor board. The case of a 70-year-old patient with breast cancer was presented: 1.0 cm grade 2 tumor with one of five positive lymph nodes, hormone receptor positive, HER2-neu negative. We discussed treatment and I still remember the spirited debate that followed. Some felt chemotherapy was a “no-brainer” while others felt very strongly that endocrine therapy was sufficient and that chemotherapy would add very little. At the time we had the TAILOR-Rx trial open, one that was prospectively evaluating the use of the 21-gene Recurrence Score. One of my colleagues had suggested talking to her about this trial.

I thought it was a great idea. In fact, it was more than a great idea — it was the most appropriate option. The situation this patient found herself in was clinical equipoise: the situation where we, as clinicians, are unsure whether treatment (or which type of treatment) provides benefit. In such a situation, there is no good evidence to guide decisions, and in reality, we make recommendations based on what we believe to be in the best interests of our particular patient and our own particular anecdotes from patients we might have treated in a similar situation.

I expected that everyone would be on board with the option to offer her the trial, but there was no unanimous consensus. Some felt it would be “not in the interests of the trial” to enroll someone “at her age,” and others thought it would be “unjust if she had to take chemotherapy.” Others felt it was fine to put her on trial because “if she didn’t like her treatment assignment, she could always withdraw.”

A few of us listened to this conversation, with each provider speaking from the point of what they truly felt was in the best interests of this patient. Ultimately, one of our most seasoned providers spoke up. “If we, as a group, feel we know the answer,” he asked, “why are we doing a trial?”

That seemed to stop everyone. “The point,” he continued, “is to go beyond anecdotes, to actually provide an evidence basis, isn’t it? In order to do that, we can’t cherry-pick the patients we place on trials just like we cannot make any one patient do a trial rather than standard of care.” With that, consensus was reached. Ultimately, the patient was offered the trial and agreed to participate.

Clinical trials are the pathway to better treatments, better outcomes, and a future without cancer. It’s not enough that trials are designed to answer important questions, or that the options for trials are available for our patients. We, as investigators, need to believe in them, and be willing to offer them to all patients who are eligible. Too often, we (myself included) make determinations that patients are best served off a clinical trial, even though they are eligible. I think we have to be cognizant of our own biases, in practice and when it comes to trials. If we hope to make expeditious progress, we have to believe there are questions we must answer, together.

Don S. Dizon is an oncologist who blogs at ASCO Connection.  This article originally appeared in the Oncologist.

Image credit: Shutterstock.com

Prev

Do uninsured patients receive more unnecessary care?

August 17, 2018 Kevin 10
…
Next

MKSAP: 77-year-old woman with frequently fluctuating INRs

August 18, 2018 Kevin 1
…

Tagged as: Oncology/Hematology

Post navigation

< Previous Post
Do uninsured patients receive more unnecessary care?
Next Post >
MKSAP: 77-year-old woman with frequently fluctuating INRs

ADVERTISEMENT

More by Don S. Dizon, MD

  • As an oncologist, this is the hardest role I play

    Don S. Dizon, MD
  • Why physicians should acknowledge the validity of second opinions

    Don S. Dizon, MD
  • A patient who taught an important lesson in doctoring

    Don S. Dizon, MD

Related Posts

  • A call to clinicians: Contrary to what you’ve been taught, use social media

    Joshua Mansour, MD
  • 13 tips for medical students starting their clinical rotations

    Netana Markovitz
  • For medical students: 20 pearls to honor every clinical rotation

    Ton La, Jr., MD, JD
  • The benefits of early clinical exposure in medical education

    Karan Patel
  • Why clinicians can’t keep ignoring care coordination

    Curtis Gattis
  • How to unite medical students in the preclinical and clinical years

    Michael Aljadah

More in Conditions

  • Why telling kids to eat less and move more fails to address obesity

    Callia Georgoulis
  • Clinical ghosts and why they haunt our exam rooms

    Kara Wada, MD
  • High blood pressure’s hidden impact on kidney health in older adults

    Edmond Kubi Appiah, MPH
  • How declining MMR vaccination rates put future generations at risk

    Ambika Sharma, Onyi Oligbo, and Katrina Green, MD
  • How one unforgettable ER patient taught a nurse about resilience

    Kristen Cline, BSN, RN
  • Why regular exercise is the best prescription for lifelong health

    George F. Smith, MD
  • Most Popular

  • Past Week

    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • The shocking risk every smart student faces when applying to medical school

      Curtis G. Graham, MD | Physician
    • Why specialist pain clinics and addiction treatment services require strong primary care

      Olumuyiwa Bamgbade, MD | Conditions
    • Harassment and overreach are driving physicians to quit

      Olumuyiwa Bamgbade, MD | Physician
    • Why so many doctors secretly feel like imposters

      Ryan Nadelson, MD | Physician
    • Why peer support can save lives in high-pressure medical careers

      Maire Daugharty, MD | Conditions
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • Why so many doctors secretly feel like imposters

      Ryan Nadelson, MD | Physician
    • Why telling kids to eat less and move more fails to address obesity

      Callia Georgoulis | Conditions
    • Why enterprise risk management is key to value-based health care success

      Olumuyiwa Bamgbade, MD | Physician
    • Rethinking physician resilience for sustainable well-being

      Sarah Webber, MD | Physician
    • How shared language saved a patient from isolation

      Syed Ahmad Moosa, MD | Physician
    • The shocking risk every smart student faces when applying to medical school

      Curtis G. Graham, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • The shocking risk every smart student faces when applying to medical school

      Curtis G. Graham, MD | Physician
    • Why specialist pain clinics and addiction treatment services require strong primary care

      Olumuyiwa Bamgbade, MD | Conditions
    • Harassment and overreach are driving physicians to quit

      Olumuyiwa Bamgbade, MD | Physician
    • Why so many doctors secretly feel like imposters

      Ryan Nadelson, MD | Physician
    • Why peer support can save lives in high-pressure medical careers

      Maire Daugharty, MD | Conditions
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • Why so many doctors secretly feel like imposters

      Ryan Nadelson, MD | Physician
    • Why telling kids to eat less and move more fails to address obesity

      Callia Georgoulis | Conditions
    • Why enterprise risk management is key to value-based health care success

      Olumuyiwa Bamgbade, MD | Physician
    • Rethinking physician resilience for sustainable well-being

      Sarah Webber, MD | Physician
    • How shared language saved a patient from isolation

      Syed Ahmad Moosa, MD | Physician
    • The shocking risk every smart student faces when applying to medical school

      Curtis G. Graham, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...